Oxford Nanopore, the UK-based DNA sequencing technology spinout of University of Oxford, went public yesterday after issuing 82.4 million shares priced at £4.25 ($5.81) each for $478m in proceeds. The initial public offering valued Oxford Nanopore at $4.7bn and existing shareholders, including commercialisation firm IP Group, offloaded $238m worth of stock. Software producer Oracle had…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.